Literature DB >> 10403066

Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort.

P Michel1, J F Dartigues, G Duru, J Moreau, R Salamon, P Henry.   

Abstract

OBJECTIVE: To assess the costs of headache-related absenteeism of community-dwelling migraineurs, and to compare the amount of absenteeism between migraineurs aged 18 and older and age, sex, and occupation-matched nonheadache-prone subjects.
DESIGN: Follow-up over a 3-month period. SAMPLES: 385 migraineurs and 313 nonheadache subjects representative of the setting.
METHODS: Every day, the participants recorded the presence of headache, if any, and the work situation (unemployment, holiday, weekend, medical reason, nonmedical reason). Sickness-related absenteeism was the number of workdays missed or interrupted for medical reasons. Headache-related absenteeism was the sickness-related absenteeism during workdays with headaches. The annual headache-related absenteeism costs in France were extrapolated from these data in accordance with the mean income per occupational category. The incremental absenteeism and related costs were the difference between the two samples.
RESULTS: Of working migraineurs, 20% had at least one period of absenteeism. During the 3 months, they missed or interrupted on average 1.4 days for medical reasons, 0.25 of which for headaches. Sickness-related absenteeism was statistically higher in migraineurs than in nonheadache-prone subjects. This difference was due to a higher absenteeism for comorbidity reasons, not for headache reasons, representing 20% of all sickness-related absenteeism. Migraineurs avoided sick leave for headache reasons. As an incremental total, 1.68 days or approximately 0.7% of the annual number of working days are lost on average per individual with migraine. The annual incremental headache-related absenteeism cost was 5.22 billions, i.e. 1,551 FF (US$240) per migraineur.

Entities:  

Mesh:

Year:  1999        PMID: 10403066     DOI: 10.1046/j.1468-2982.1999.019005503.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

Review 1.  Relevance of cortical thickness in migraine sufferers.

Authors:  Nouchine Hadjikhani
Journal:  Expert Rev Neurother       Date:  2008-03       Impact factor: 4.618

Review 2.  [Socio-economic impact of migraine and headaches in France].

Authors:  Jean-Paul Auray
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  The Impact of Self-Reported Recurrent Headache on Absenteeism and Presenteeism at Work Among Finnish Municipal Female Employees.

Authors:  Kirsi Malmberg-Ceder; Tiina Vuorio; Päivi E Korhonen; Hannu Kautiainen; Seppo Soinila; Maija Haanpää
Journal:  J Pain Res       Date:  2020-08-21       Impact factor: 3.133

4.  The impact of anaemia and its treatment on employee disability and medical costs.

Authors:  Ernst Berndt; William Crown; Joel Kallich; Stacey Long; Xue Song; Gary H Lyman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Authors:  André Pradalier; Jean-Paul Auray; Abdelkader El Hasnaoui; Kazem Alzahouri; Jean-François Dartigues; Gérard Duru; Patrick Henry; Michel Lantéri-Minet; Christian Lucas; Guy Chazot; Anne-François Gaudin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 6.  Impact of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andrée
Journal:  J Headache Pain       Date:  2008-04-17       Impact factor: 7.277

7.  Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial.

Authors:  Muhammad Amer; Mark Woodward; Lawrence J Appel
Journal:  BMJ Open       Date:  2014-12-11       Impact factor: 2.692

8.  Acupuncture reduced the medical expenditure in migraine patients: Real-world data of a 10-year national cohort study.

Authors:  Sheng-Ta Tsai; Chun-Hung Tseng; Mei-Chen Lin; Hsien-Yin Liao; Boon-Khai Teoh; Shao San; Chon-Haw Tsai; Hung-Yu Huang; Yi-Wen Lin
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.